Reported positive Phase 2b RewinD-LB clinical data at CTAD 2025; additional analyses to be presented at AD/PD 2026 ...
Militaries use AI for rapid threat detection and target analysis, as adversaries deploy it to fabricate victories before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results